HUT36859A - Tumer-specific monoclinal antibodies - Google Patents

Tumer-specific monoclinal antibodies

Info

Publication number: HUT36859A
Authority: HU; Hungary
Prior art keywords: tumer; monoclonal antibodies; specific; relates; diagnostic procedures
Prior art date: 1984-01-31

Application number

HU85344A

Other languages

English (en)

Other versions

HU209519B (en

Inventor

Michael Hanna

Martin Haspel

Herbert Hoover

Original Assignee

Litton Bionetics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-01-31

Filing date

1985-01-30

Publication date

1985-10-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24300700&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUT36859(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-01-30 Application filed by Litton Bionetics Inc filed Critical Litton Bionetics Inc

1985-10-28 Publication of HUT36859A publication Critical patent/HUT36859A/hu

1994-06-28 Publication of HU209519B publication Critical patent/HU209519B/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3046—Stomach, Intestines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Cell Biology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

HU85344A 1984-01-31 1985-01-30 Process for preparing monoclonal antibodies having specificity for tumor, hybridomas produced them and vaccines HU209519B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US57553384A	1984-01-31	1984-01-31

Publications (2)

Publication Number	Publication Date
HUT36859A true HUT36859A (en)	1985-10-28
HU209519B HU209519B (en)	1994-06-28

Family

ID=24300700

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HU85344A HU209519B (en)	1984-01-31	1985-01-30	Process for preparing monoclonal antibodies having specificity for tumor, hybridomas produced them and vaccines

Country Status (15)

Country	Link
EP (1)	EP0151030B1 (hu)
JP (2)	JPH0759518B2 (hu)
AT (1)	ATE71410T1 (hu)
AU (2)	AU589351B2 (hu)
CA (1)	CA1340781C (hu)
DE (1)	DE3585093D1 (hu)
DK (1)	DK171896B1 (hu)
ES (1)	ES8802621A1 (hu)
GR (1)	GR850179B (hu)
HU (1)	HU209519B (hu)
IE (1)	IE58859B1 (hu)
IL (1)	IL74156A (hu)
NZ (1)	NZ210867A (hu)
PT (1)	PT79894B (hu)
ZA (1)	ZA85689B (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3319751A1 (de) *	1983-05-31	1984-12-06	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen	Verfahren zur gewinnung von gegen tumorantigene gerichteten monoklonalen antikoerpern und diese enthaltende arzneimittel
US6294172B1 (en)	1983-08-12	2001-09-25	Dade Behring Marburg Gmbh	Monoclonal antibodies with specificity for membrane-associated antigens
DE3629640A1 (de) *	1986-08-30	1988-03-03	Behringwerke Ag	Verwendung monoklonaler antikoerper zur therapie von tumoren
US5011684A (en) *	1985-09-05	1991-04-30	Beth Israel Hospital Association	Lysing or blocking unwanted cells with IL-2 receptor-specific binding substance
JPS6283898A (ja) *	1985-10-09	1987-04-17	Kyowa Hakko Kogyo Co Ltd	抗ヒト肺腺癌特異的単クロ−ン性抗体
US5552291A (en) *	1985-10-09	1996-09-03	Kyowa, Hakko Kogyo Co., Ltd.	Anti-human pulmonary adenocarcinoma specific monoclonal antibody
EP0222360A3 (en) *	1985-11-12	1989-03-15	Biotherapeutics Inc.	A method of producing a patient-specific cytotoxic reagent and composition
JPS62207298A (ja) *	1986-03-06	1987-09-11	Kyowa Hakko Kogyo Co Ltd	抗ヒト胃癌単クロ−ン性抗体
JPH06100843B2 (ja) *	1986-06-23	1994-12-12	キヤノン株式会社	絶縁性磁性乾式現像剤
NZ222166A (en) *	1986-10-14	1991-03-26	Bunge Australia	Monoclonal antibodies against equine chorionic gonadotrophin (ecg), cell-lines, assays, ecg purification and pharmaceutical compositions
DK169987D0 (da) *	1987-04-03	1987-04-03	Jens Christian Jensenius	Human tumor-associated antigen, ca-ou1
WO1989000050A1 (en) *	1987-07-02	1989-01-12	Akzo N.V.	Antigen recognized by mca 16-88
US5215913A (en)	1987-11-30	1993-06-01	Roger Williams General Hospital	IgG-1 human monoclonal antibody reactive with an HIV-1 antigen and methods of use
DE3909799A1 (de)	1989-03-24	1990-09-27	Behringwerke Ag	Monoklonale antikoerper (mak) gegen tumorassoziierte antigene, ihre herstellung und verwendung
DK0429624T3 (da) *	1989-06-19	1994-05-30	Akzo Nobel Nv	Radioimmunterapi under anvendelse af alfa-partikelemission
AU660927B2 (en) *	1990-04-12	1995-07-13	Akzo N.V.	CTAA 28A32, the antigen recognized by MCA 28A32
WO1992000763A1 (en) *	1990-07-03	1992-01-23	Akzo N.V.	Immunoreactive compound
US5281710A (en) *	1990-08-01	1994-01-25	The Scripps Research Institute	Dynemicin analogs: synthesis, methods of preparation and use
AU656785B2 (en) *	1991-05-16	1995-02-16	Akzo N.V.	Tumor associated monoclonal antibody 81AV78
IL103758A (en) *	1991-12-13	1998-07-15	Akzo Nv	Cancer-specific monoclonal antibodies
JPH06113831A (ja) *	1992-04-08	1994-04-26	Dev Center For Biotechnol	ハイブリドーマおよびその抗体
EP0650735A3 (en) *	1993-07-09	1999-04-14	Akzo Nobel N.V.	Kit and method for pretargeting
CA2476999C (en)	2002-02-22	2015-09-15	Intracel Resources Llc	Sterile immunogenic non-tumorigenic tumor cell compositions and methods
US7176022B2 (en) *	2002-12-20	2007-02-13	Cell Genesys, Inc.	Directly injectable formulations which provide enhanced cryoprotection of cell products
CN106133521A (zh) *	2013-10-02	2016-11-16	苏瑞科技有限公司	用于治疗异质肿瘤的病患特异性的免疫疗法
EP3409297A1 (en)	2017-05-30	2018-12-05	AlfaRim Medial Holding B.V.	The optimal 225actinium--213bismuth generator for alpha-particle radioimmunotherapy
WO2019057598A1 (en)	2017-09-20	2019-03-28	Alfarim Medical Holding B.V.	OPTIMAL 225ACTINIUM - 213BISMUTH GENERATOR FOR ALPHA PARTICLE RADIO IMMUNOTHERAPY

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU4322879A (en) *	1978-01-11	1979-07-19	Massachusetts General Hospital, The	Producing antibodies
DE3211356A1 (de) *	1982-03-27	1983-09-29	Behringwerke Ag, 3550 Marburg	Zell-hybrid, verfahren zu seiner herstellung sowie seine verwendung
JPS59137497A (ja) *	1983-01-20	1984-08-07	ザ・リ−ジエンツ・オブ・ザ・ユニバ−シテイ・オブ・カリフオルニア	抗原特異的免疫グロブリン生産性ヒト／ヒトハイブリド−マ及びその生産する抗体
JPS58201994A (ja) *	1982-05-21	1983-11-25	Hideaki Hagiwara	抗原特異的ヒト免疫グロブリンの生産方法
US4613576A (en) *	1983-03-09	1986-09-23	Sloan-Kettering Institute For Cancer Research	Human monoclonal antibodies to cancer cells

1985
- 1985-01-17 NZ NZ210867A patent/NZ210867A/xx unknown
- 1985-01-22 GR GR850179A patent/GR850179B/el unknown
- 1985-01-23 AU AU37992/85A patent/AU589351B2/en not_active Ceased
- 1985-01-25 IL IL74156A patent/IL74156A/xx not_active IP Right Cessation
- 1985-01-25 IE IE19285A patent/IE58859B1/en not_active IP Right Cessation
- 1985-01-28 PT PT79894A patent/PT79894B/pt not_active IP Right Cessation
- 1985-01-29 ZA ZA85689A patent/ZA85689B/xx unknown
- 1985-01-30 HU HU85344A patent/HU209519B/hu not_active IP Right Cessation
- 1985-01-30 DE DE8585300610T patent/DE3585093D1/de not_active Expired - Lifetime
- 1985-01-30 AT AT85300610T patent/ATE71410T1/de not_active IP Right Cessation
- 1985-01-30 EP EP85300610A patent/EP0151030B1/en not_active Expired - Lifetime
- 1985-01-30 DK DK040885A patent/DK171896B1/da not_active IP Right Cessation
- 1985-01-30 CA CA000473130A patent/CA1340781C/en not_active Expired - Lifetime
- 1985-01-30 ES ES539987A patent/ES8802621A1/es not_active Expired
- 1985-01-31 JP JP60017692A patent/JPH0759518B2/ja not_active Expired - Lifetime
1989
- 1989-12-29 AU AU47367/89A patent/AU635511B2/en not_active Ceased
1993
- 1993-10-27 JP JP5269230A patent/JP2516731B2/ja not_active Expired - Lifetime

Also Published As

Publication number	Publication date
JPH06315395A (ja)	1994-11-15
PT79894B (en)	1986-10-23
EP0151030B1 (en)	1992-01-08
NZ210867A (en)	1989-01-06
DK40885A (da)	1985-10-25
AU635511B2 (en)	1993-03-25
ES8802621A1 (es)	1988-09-16
HU209519B (en)	1994-06-28
GR850179B (hu)	1985-05-23
IL74156A0 (en)	1985-04-30
DE3585093D1 (de)	1992-02-20
AU589351B2 (en)	1989-10-12
AU3799285A (en)	1985-08-08
ES539987A0 (es)	1988-09-16
JP2516731B2 (ja)	1996-07-24
PT79894A (en)	1985-02-01
CA1340781C (en)	1999-10-12
JPS60260597A (ja)	1985-12-23
ATE71410T1 (de)	1992-01-15
IE58859B1 (en)	1993-11-17
JPH0759518B2 (ja)	1995-06-28
IE850192L (en)	1985-07-31
ZA85689B (en)	1986-04-30
AU4736789A (en)	1990-05-03
DK171896B1 (da)	1997-08-04
EP0151030A2 (en)	1985-08-07
DK40885D0 (da)	1985-01-30
IL74156A (en)	1990-08-31
EP0151030A3 (en)	1987-11-25

Publication	Publication Date	Title
GR850179B (hu)	1985-05-23
ZA833686B (en)	1984-09-26	Human human hybridomas for cervical carcinoma
IL80231A (en)	1991-08-16	Monoclonal anti-human breast cancer antibodies and hybridomas producing them,and diagnosis of human breast tumors
MX9705349A (es)	1998-07-31	Anticuerpo monoclonal 1a7 y su uso para el tratamiento de melanona y carcinoma de celulas pequeñas.
EP0256714A3 (en)	1989-11-08	Combination therapy using anti-tumor monoclonal antibodies and/or immunotoxins with interleukin-2
ATE71225T1 (de)	1992-01-15	Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnoseoder therapieverfahren bezueglich krebskrankheiten.
EP0328578A4 (en)	1990-04-10	ANTIGEN IDENTIFIED BY MCA 16-88.
EP0440689A4 (en)	1991-11-27	Anti-idiotypic antibody induction of antitumor response
FI935038A0 (fi)	1993-11-15	Tumoer associerad monoklonal antikropp 81AV78
EP0537168A4 (en)	1993-05-05	Ctaa 28a32, the antigen recognized by mca 28a32
Ferrone et al.	1993	Active Specific Immunotherapy of Malignant Melanoma with Anti‐idiotypic Monoclonal Antibodies
NO924803L (no)	1993-06-14	Tumor-relatert monoklonalt antistoff 88bv59
ZA878077B (en)	1988-04-25	Murine hybridoma lym-2 and diagnostic antibody produced thereby

Legal Events

Date	Code	Title	Description
2001-03-28	HPC4	Succession in title of patentee	Owner name: INTRACEL NETHERLANDS, B.V., NL
2002-10-28	HMM4	Cancellation of final prot. due to non-payment of fee